Flynn Daniel Lee
- SEC CIK
- 0001713712
No open-market purchases or sales filed in the past year.
Current role at each company
- DCPH Deciphera Pharmaceuticals, Inc.Chief Scientific Officeras of Jun 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Flynn Daniel Lee as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 (view filing) | Jun 16 | 5 days | Flynn Daniel LeeChief Scientific Officer | SSale | −1.66K | $14.40 | −$23.8K | −2.8%57.2K after | |
| Feb 17, 2023 (view filing) | Feb 16 | 1 day | Flynn Daniel LeeChief Scientific Officer | SSale | −1.37K | $15.10 | −$20.7K | −2.3%58.8K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Flynn Daniel LeeChief Scientific Officer | SSale | −2.40K | $21.24 | −$51.0K | −5.2%43.7K after | |
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | Flynn Daniel LeeChief Scientific Officer | SSale | −1.77K | $10.75 | −$19.0K | −3.7%46.1K after | |
| Feb 18, 2022 (view filing) | Feb 16 | 2 days | Flynn Daniel LeeChief Scientific Officer | SSale | −1.37K | $9.05 | −$12.4K | −2.8%47.9K after |